Bioregenx BRGX
OTC BRGX
$0.01 +0.00 (+0.00%)
At close: Sep 21, 2026 · 4:00 PM EDT

Bioregenx (BRGX) Cash from Financing Activities (2022 - 2026)

Bioregenx (BRGX) posted Cash from Financing Activities of -$50206.0 for Q1 2026, down 13.73% on a QoQ basis from -$44143.0 in Q4 2025, and down 382.05% year-over-year from $17800.1 in Q1 2025.

Analysis

Bioregenx (BRGX) Cash from Financing Activities (2022 - 2026) Analysis & Trends

Bioregenx has reported Cash from Financing Activities for 5 years, with the latest figure at -$50206.0 in Q1 2026.

  • On a quarterly basis, Cash from Financing Activities fell 382.05% year-over-year to -$50206.0 in Q1 2026; TTM through Mar 2026 was -$6693.0, a 104.49% decrease from a year earlier, with the FY2025 full-year figure at $33098.0, down 92.51% from the prior year.
  • Cash from Financing Activities was -$50206.0 for Q1 2026 at Bioregenx, down from -$44143.0 in the prior quarter.
  • The five-year high for Cash from Financing Activities was $513370.0 in Q4 2023, with the low at -$50206.0 in Q1 2026.
  • Average Cash from Financing Activities over 5 years is $104393.9, with a median of $39118.5 recorded in 2022.
  • The sharpest annual moves came in 2023 and 2025: Cash from Financing Activities jumped 14571.91% in 2023, then tumbled 535.7% in 2025.
  • Over 5 years, Cash from Financing Activities stood at $3499.0 in 2022, then surged by 14571.91% to $513370.0 in 2023, then sank by 101.35% to -$6944.0 in 2024, then sank by 535.7% to -$44143.0 in 2025, then retreated by 13.73% to -$50206.0 in 2026.
  • The last three Cash from Financing Activities figures came in at -$50206.0 (Q1 2026), -$44143.0 (Q4 2025), and $70833.0 (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing (Qtr)
1 Abbott Laboratories 179.49 Bn 174.54 Bn 7.27 Bn -3.52 Bn
2 Intuitive Surgical 142.30 Bn 137.21 Bn 1.96 Bn -287.90 Mn
3 Medtronic 116.24 Bn 108.04 Bn 6.34 Bn -343.00 Mn
4 Stryker 105.51 Bn 102.03 Bn 4.50 Bn -95.00 Mn
5 Boston Scientific 65.13 Bn 64.83 Bn 3.85 Bn -410.00 Mn
6 Edwards Lifesciences 51.20 Bn 47.05 Bn 1.35 Bn -300,000.00
7 Dexcom 33.79 Bn 31.84 Bn 830.00 Mn -607.30 Mn
8 Resmed 32.01 Bn 30.54 Bn 861.22 Mn -263.16 Mn
9 Alcon 31.98 Bn 30.52 Bn 1.68 Bn -510.00 Mn
10 Bioregenx 9.72 Mn 9.67 Mn 348,288.00 -50,206.00
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -50,206.00
Dec 31, 2025 -44,143.00
Sep 30, 2025 70,833.00
Jun 30, 2025 16,823.00
Mar 31, 2025 -10,415.00
Dec 31, 2024 -6,944.00
Sep 30, 2024 46,442.00
Jun 30, 2024 120,059.00
Mar 31, 2024 282,562.00
Dec 31, 2023 513,370.00
Sep 30, 2023 116,108.00
Jun 30, 2023 410,105.00
Mar 31, 2023 164,739.00
Dec 31, 2022 3,499.00
Sep 30, 2022 5,676.00
Jun 30, 2022 31,795.00
API Access

Bioregenx Cash from Financing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-financing-activities&ticker=BRGX&period=max&api_key=YOUR_API_KEY